HROW Harrow Health Inc.
Health Care, filed as HARROW HEALTH INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab
Bought by 1 manager in 2026 Q2, sold by 1
In 2026 Q2 Ron Baron opened a position in Harrow Health, while James Silverman trimmed.
Who owns this now
Largest portfolio weights among holders, up to 9.2% (James Silverman, Opaleye Management). Not free-float ownership.
Who owns HROW
Sorted by value, long equity only, as of 2026 Q2.
| History | |||||
|---|---|---|---|---|---|
| James Silverman, Opaleye Management | Reduce −15.3% | 2,400,000 | $102M | History | |
| Ron Baron, Bamco Inc. (Baron Capital) | New 0.05% | 809,350 | $34M | History |
Insider trades
Open-market buys and sales by HROW's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $469K bought by 4 insiders
- $9.6M sold by 2 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Amir Shojaei Chief Scientific OfficerSale$450K 11,250 shares at $40.00 100% of stakeTraded Aug 14 Filed Aug 17
-
Adrienne L Graves DirectorBuy$31K 1,000 shares at $31.07 New stakeTraded May 18 Filed May 19
-
Lauren P Silvernail DirectorBuy$31K 1,000 shares at $31.00 New stakeTraded May 18 Filed May 19
-
Mark L Baum CEOBuy$302K 10,000 shares at $30.20 +0.3% to stakeTraded May 14 Filed May 15
-
Andrew R. Boll CFOBuy$105K 3,500 shares at $29.90 +0.4% to stakeTraded May 14 Filed May 15
-
Opaleye Management Inc. 10% ownerSale$7.8M 198,572 shares at $39.51 77% of stakeTraded Mar 3–4 Filed Mar 5
-
Opaleye Management Inc. 10% ownerSale$271K 5,000 shares at $54.18 7.1% of stakeTraded Feb 27 Filed Mar 3
-
Opaleye Management Inc. 10% ownerSale$1.1M 20,000 shares at $53.35 22% of stakeTraded Jan 6 Filed Jan 8
Also filed in the last 12 months, not counted as buying or selling: 3 option exercises and 2 share withholdings for taxes.
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 1.01,2.01,7.01,9.01 | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 1.01,7.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 1.01,2.03,8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| 8-K | 2.02,5.02,9.01 | Filing Doc | |
| 8-K | 2.01,3.02,8.01,9.01 | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc |
No filings match this filter.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Income statement
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $139.48M | $189.65M | $211.75M |
| Total non-current assets * | $172.68M | $199.32M | $187.73M |
| Total assets | $312.16M | $388.97M | $399.48M |
| Total current liabilities | $49.34M | $91.34M | $96.3M |
| Total non-current liabilities * | $192.41M | $228.33M | $251.09M |
| Total equity | $70.77M | $69.65M | $52.45M |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.